IMF I would say, shareholders have very little rights and even via IMF you will most likely get very little back as a portion of your investment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025